About Sungano Mharakurwa
Sungano is the scientific director for the Malaria Institute at Macha, and a senior research associate in the Bloomberg Schools Department of Molecular Microbiology and Immunology and at the Johns Hopkins Malaria Institute where he is investigating public health strategies for delaying or minimizing the evolution of Plasmodium falciparum resistance to antimalarial drugs. Currently examining the field dynamics and determinants of drug-resistant P. falciparum alleles in human and vector phases in order to identify potential targets for containment approaches. Previous work included the relationship of Plasmodium falciparum transmission control on levels of multigenic drug resistance. Parallel studies explore the development of non-invasive methods for the detection of P. falciparum malaria using human saliva and urine samples.
Role(s) / Profession(s)
Johns Hopkins Malaria Research Institute - JHMRI
Website: http://malaria.jhsph.edu/ Type: Academic Institution Country: United States About: The Johns Hopkins Malaria Research Institute is a broad program of basic-science research to treat and control malaria, develop a vaccine and find new drug targets to prevent and cure this deadly disease. JHMRI is taking a multidisciplinary approach to understanding the Plasmodium parasite, the mosquito and the genes and proteins involved in the transmission of malaria.
Macha Malaria Research Institute - MMRI
Website: http://machamalaria.org/ Type: Non-Governmental Organization Country: Zambia About: The Malaria Institute at Macha (MIAM) is a joint collaborative effort - to develop a center of excellence in rural Zambia that will carry out state-of-the-art malaria research - including molecular biology, entomology, epidemiology and clinical studies. The partners involved in this effort are the Johns Hopkins Bloomberg School of Public Health; Macha Malaria Research Institute (MMRI), which is a US-based non profit organization; Macha Mission Hospital in southern Zambia; and the Zambian government through its Ministry of Health. Our vision is that some day malaria will no longer cause such a heavy burden of suffering and death in children living in this part of Africa.
- United States
- Moderator Malaria Treatment & Prevention
Thanks to all for this great discussion. Bill makes a compelling case and brings to light an effective approach against malaria that has been largely forgotten for some reason. Simple housing improvements like screening can dramatically control malaria (see: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2688520/pdf/1475-2875-8-108.pdf; http://onlinelibrary.wiley.com/doi/10.1046/j.1365-3156.2003.01059.x/pdf). It needs to be recognized that LLINs use a ...
Sungano Mharakurwa replied to "Lessons learned from Zambia: Discuss with Dr. Phil Thuma" in the Malaria Treatment & Prevention community.
Thanks again to everyone that shared thoughts on the Macha field experience. A short briefing is now available http://www.ghdonline.org/malaria/discussion/lessons-learned-from-zambia-discuss-with-dr-phil-t/brief/ Best Wishes
Dear All, Many thanks to those who have taken the time to introduce themselves. This is helpful to know each other and get a sense of the repertoire of expertise and work done in the community. If you have not already done so, perhaps you could briefly introduce yourself as ...
Sungano Mharakurwa started a discussion "Lessons learned from Zambia: Discuss with Dr. Phil Thuma". in the Malaria Treatment & Prevention community.
Dear Colleagues, Phil Thuma, MD, is Senior Scientific Advisor and founder of the Macha Research Trust (MRT), doing business as the Malaria Institute at Macha (MIAM) in Zambia. The institute is a collaborative effort to develop a regional center of excellence for research and education on malaria and other major ...
Sungano Mharakurwa recommended "Artemisinin Resistance Malaria is Spreading --The Lancet" in the community.